Journals / Clinical and Experimental Health Sciences / 2022 / Cilt: 12 - Sayı: 1

Breast Cancer in Men: Risk Factors, Treatment Options, Quality of Life: Systematic Review

Pages
257–267
Publication Date
2022-03-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: This study indicated that many risk factors played a role in the development and prognosis of breast cancer among men and their survival rate, that mastectomy was the primary treatment option, and that patients’ quality of life was adversely affected during/following the disease.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim was to systematically examine the risk factors that have a role in the development and prognosis regarding the breast cancer among men and patients’ survival rate, and the studies performed to determine the treatment methods and patients’ quality of life.
📊
Key Findings & Data:Case-control and cohort studies published between 2000 and 2020 were included.
💡
Conclusion & Impact:Conclusion: This study indicated that many risk factors played a role in the development and prognosis of breast cancer among men and their survival rate, that mastectomy was the primary treatment option, and that patients’ quality of life was adversely affected during/following the disease.
🔬Design:Review & Systematic Survey
📍Scope:2000 Verileri
⚙️Variables:male breast cancer · risk factors · treatment

Abstract

Objective: The aim was to systematically examine the risk factors that have a role in the development and prognosis regarding the breast cancer among men and patients’ survival rate, and the studies performed to determine the treatment methods and patients’ quality of life. Methods: The databases of PubMed, Scopus, Cochrane Library, OVID-LWW, Medline Complete, Science Direct, Taylor&Francis, ULAKBIM, Ethos, OpenThesis, Open Dissertation, ProQuest Dissertations & Theses Global, and National Center of Theses were used to screen the literature. Case-control and cohort studies published between 2000 and 2020 were included. Following the screening activity, 14 studies were included in the systematic review. Results: This study involved seven cohort and seven case-control studies. Most of the patients were followed with invasive carcinoma diagnosis. These studies aimed to examine the genetic mutations and impacts of environmental, anthropometric and hormonal factors in regard to the risk factors. The factors such as the molecular classification of cancer, presence of genetic mutation, cancer stage and treatment methods affected the prognosis and survival rate. Mastectomy was used as the first treatment option, and this process had adverse impacts on patients’ quality of life physically, mentally and emotionally. Conclusion: This study indicated that many risk factors played a role in the development and prognosis of breast cancer among men and their survival rate, that mastectomy was the primary treatment option, and that patients’ quality of life was adversely affected during/following the disease.

🔖

Cite This Article

AYGİN, D., YAMAN, Ö. (2022). Breast Cancer in Men: Risk Factors, Treatment Options, Quality of Life: Systematic Review. Clinical and Experimental Health Sciences, Cilt: 12 - Sayı: 1, 257–267. https://ajindex.com/articles/481413

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Andrykowski MA. Physical and mental health status and health behaviors in male breast cancer survivors: A national, population-based, case-control study. Psychooncology 2012;21(9):927–34
  2. Keinan-Boker L, Levine H, Leiba A, Derazne E, Kark JD. Adolescent obesity and adult male breast cancer in a cohort of 1,382,093 men. Int J Cancer 2018;142(5):910–8
  3. Key Statistics for Breast Cancer in Men. https://www.cancer.org/cancer/breast-cancer-in-men/about/key-statistics.html. American Cancer Society.Accessed 28 April 2020 4. Andre S, Pereira T, Silva F, Machado P, Vaz F, Aparıcio M, et al. Male breast cancer: Specific biological characteristics and survival in a Portuguese cohort. Mol Clin Oncol 2019;(10):644–54
  4. Turashvili G, Gonzalez-Loperena M, Brogi E, Dickler M, Norton L, Morrow M, et al. The 21-Gene Recurrence Score in Male Breast Cancer. Ann Surg Oncol 2018;25(6):1530–5
  5. Guenel P, Cyr D, Sabroe S, Lynge E, Merletti F, Ahrens W, et al. Alcohol Drinking May Increase Risk of Breast Cancer in Men: A European Population-Based Case–Control Study. Cancer Causes Control 2004;15(6):571–80
  6. Palli D, Falchetti M, Masala G, Lupi R, Sera F, Saieva C, et al. Association between the BRCA2 N372H variant and male breast cancer risk: A population-based case-control study in Tuscany, Central Italy. BMC Cancer 2007;7:1–7
  7. Ottini L, Rizzolo P, Zanna I, Silvestri V, Saieva C, Falchetti M, et al. Association of SULT1A1 Arg213His polymorphism with male breast cancer risk: results from a multicenter study in Italy. Breast Cancer Res Treat 2014;148(3):623–8
  8. Breast Cancer in Men: Risk Factors. https://www.cancer.net/cancer-types/breast-cancer-men/risk-factors. Accessed 28 April 2020 10. Breast Cancer in Men: Types of Treatment. https://www.cancer.net/cancer-types/breast-cancer-men/types-treatment. Accessed 28 April 2020 11. Male Breast Cancer. https://www.breastcancer.org/symptoms/types/male_bc?gclid=EAIaIQobChMIzZi30amL6QIVycmyCh3NfgxNEAAYAiAAEgKKSfD_BwE. Accessed 28 April 2020 12. Son BH, Ahn SH, Kim SW, Kang E, Park SK, Lee MH, et al. Prevalence of BRCA1 and BRCA2 mutations in non-familial breast cancer patients with high risks in Korea: The Korean Hereditary Breast Cancer (KOHBRA) Study. Breast Cancer Res Treat 2012;133(3):1143–52
  9. Rugo HS, Brufsky AM, Yood MU, Tripathy D, Kaufman PA, Mayer M, et al. Racial disparities in treatment patterns and clinical outcomes in patients with HER2-positive metastatic breast cancer. Breast Cancer Res Treat 2013;141(3